ARRAIL Group (06639) announced that for the six months ending September 30, 2025, the Group expects to achieve a pre-tax profit of no less than RMB 20 million, compared to approximately RMB 7.4 million for the same period in 2024. The anticipated increase in profit is primarily attributed to: operational improvements driven by the Group's AI-powered clinical and business management systems; sustained recovery in patient demand and service volume; and the Group's stringent cost-reduction and efficiency-enhancement initiatives.